引智天下

反倾销反补贴及其他贸易救济服务

支持反倾销、反补贴、保障措施等贸易救济调查与应诉，协助证据准备、问卷答复及听证策略。

反垄断申报

提供经营者集中申报方案与材料准备，沟通监管机关并协调补救措施，确保及时取得反垄断批准。

审计

提供法定及专项审计服务，支持财务报表审计、内控评估与监管/投资人报告需求。

借壳上市/反向收购

提供借壳上市/反向收购方案设计与落地支持，涵盖壳资源筛选、交易架构、监管路径与信息披露合规。

中国ODI核准/备案

协助完成中国对外投资ODI核准/备案及相关外汇流程，对接发改、商务等主管部门，确保全程合规。

海关合规服务

提供海关合规咨询，涵盖归类、估价、原产地规则、稽核应对与风险防控，提升通关效率与合规水平。

网络安全与数据保护

提供网络安全与数据保护合规建议，涵盖制度治理、应急预案、整改落地及数据跨境传输合规。

争议解决

提供商业争议解决服务，涵盖谈判、调解、仲裁与诉讼，制定策略并进行全流程案件管理。

尽职调查

开展法律、财务、税务与合规尽调，识别重大风险与交易障碍，支撑决策与交易架构设计。

环保

提供环保合规咨询，涵盖环评与许可、EHS管理及可持续要求，评估并整改环境风险。

出口管制与合规服务

建立出口管制合规体系，开展物项分类、主体筛查与许可管理，并应对执法调查，降低跨境合规风险。

东道国投资审批

协助办理东道国投资审批及行业许可，涵盖外资审查、牌照申请与登记备案，保障项目顺利落地。

人力资源

提供人力资源咨询，涵盖招聘用工、薪酬激励、制度建设与劳动合规，并支持跨境派遣与组织优化。

首次公开发行并上市

提供IPO筹备与上市全流程支持，涵盖治理完善、合规整改、申报文件支持及中介协调。

破产与重组

提供破产程序与重组方案咨询，涵盖债权人沟通、债务重整与资产处置，提升价值回收与经营延续性。

国际工程承包

提供国际工程承包（EPC）全链条支持，涵盖投标策略、合同起草谈判、索赔管理与合规风控。

国际物流

提供国际物流方案设计与协调，优化线路、成本与时效，并结合贸易条款与通关要求进行风险管控。

投资协议起草审阅

起草、审阅并协商投资协议（意向书、股权/资产购买及股东协议等），明确权责、控制安排与交割条件。

投资标的筛选与匹配服务

通过行业梳理、财务筛选与匹配度评估，筛选并匹配投资标的，形成高质量项目储备。

法律实体设立与存续

提供设立到存续全流程服务，涵盖注册登记、公司秘书、治理更新与年度申报，确保持续合规运营。

生命科学

提供生命科学领域合规与交易支持，涵盖准入监管、临床与质量合规、许可备案及行业专项风控。

常年法律顾问

提供常年法律顾问服务，覆盖日常咨询、合同审阅、合规支持与紧急事项响应，保障经营稳定。

其他贸易相关服务(贸易融资、贸易保险、报关报检、贸易代理、出口退税、产品认证与检测服务)

提供贸易融资、贸易保险、报关报检、贸易代理、出口退税及产品认证与检测等综合贸易配套服务。

证券/基金/期货/保险/信贷

提供证券、基金、期货、保险及信贷等金融业务咨询，涵盖牌照申请、合规运营、产品结构设计与监管报告。

税务筹划

规划税收高效架构，妥善处理转让定价与双重征税，支持申报与落地，降低税负并确保合规。

技术与知识产权

提供技术与知识产权战略支持，涵盖布局规划、申请维护、许可与转让安排，保护核心创新成果。

Beijing Tigermed-Jyton Co., LTD. ——Project Management

We have a senior project management team with years of expertise in various fields such as medical aesthetics, cardiovascular, ophthalmology, AI, surgical robots, and oncology. We have built thorough analysis of the current situation and future developments in these fields. Relying on a strong medical team and years of solid cooperation with the study sites, we have accumulated unique advantages and rich experiences in the project management for innovative devices. Tigermed-Jyton is customer-oriented and adopts a project management model where the project manager serves as a one-stop contact point for the sponsors, assisting them in coordinating other functional teams to improve communication efficiencies. The project manager regularly analyzes the deviations between plans and actual progress, as well as manages and prevents risks, ensuring that the project proceeds as scheduled. 1. Preparation of project plan 2. Clinical trial risk management 3. Clinical trial document management 4. Clinical trial financial management 5. Clinical trial meeting organization 6. Project training 7. Relevant supplier management

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——Clinical Monitoring

We have a monitoring team with more than 200 CRAs in China, and more than 800 CRAs globally. We can provide local clinical monitoring and site management services. We are familiar with the study site process, and provide more convenient support and more professional services for the study sites. Our services include: 1. Study site screening 2. Ethics Committee filing and approval 3. Study site clinical trial agreement negotiation 4. Study site initiation and close-out 5. Study site monitoring and management 6. Investigational product management

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——Medical Writing

The medical writing team consists of dozens of excellent medical experts, writing specialists and statisticians. Core members have an average industry experience of more than 10 years and academic background of leading medical schools globally. Our innovative protocol design concept, scientific and rigorous work style, rich medical writing experience and effective SOPs have won the team a good reputation in the industry. Our service content includes the following: 1. Design of clinical trial protocols for medical devices / different phases of clinical trial protocols or unconventional study protocols for drugs 2. Preparation of clinical protocol related documents (e.g., case report forms, informed consent forms, and investigator’s brochure) 3. Preparation of clinical study report 4. Publishing papers on core journals 5. Preparation of medical materials for clinicians (e.g., questionnaire on updating treatment guidelines)

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. —— Clinical Evaluation Report

Medical device clinical evaluation refers to the process where the manufacture validates whether the product meets the operational requirements or falls within the applicable scope through clinical literature, clinical data, and clinical trial. We can provide Clinical Evaluation Report (CER) writing service that comply with regulatory requirements from both NMPA (National Medical Products Administration) and IMDRF (International Medical Device Regulators Forum) for regions covered by these regulations. Tigermed-Jyton has established partnerships with over a hundred well-known medical device companies globally. Most of the top 30 global medical device companies are our long-term clients. We have rapidly and professionally completed over 200 medical device clinical evaluation reports, covering more than 20 therapeutic areas, including cardiovascular, orthopedics, endocrinology, surgery, dentistry, imaging, and neurology, and others. Our team's strengths include reasonable and accurate technical comparisons, comprehensive and precise literature search and screening, rapid and accurate data extraction, adverse event information compilation, professional statistical analysis, and high-quality medical writing. With our extensive project experience and expertise, we are able to quickly and accurately write high-quality clinical evaluation reports in Chinese and English for medical device companies, including: Based on China's NMPA Requirements: 1. Clinical Evaluation Exemption Report: This report provides a comparison explanation for medical devices that are listed in the catalog for products exempted from clinical evaluation. 2. Predicate device clinical evaluation report 3. Overseas clinical trial / MRCT clinical evaluation report Based on EU MDR Requirements: EU MDR certified CER Clinical Evaluation Strategies and Scientific Evidence: 1. Feasibility assessment report of clinical evaluation pathway for product registration (Providing companies with registration / clinical evaluation pathway decision references based on their individual strategic business needs) 2. Clinical evaluation related literature search, screening, qualitative and quantitative analysis report 3. Meta-analysis 4. Systematic reviews 5. Journal writing & publication

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——GSP System Counseling

Medical device distributors should comply with the requirements of regulations such as the “Good Service Practice of Medical Device”. Our GSP compliance related consulting services include: 1. Collection and dissemination of medical device operation regulations 2. Establishment of management GSP system and personnel training 3. Business management software recommendation 4. Evaluation and selection of third-party distribution agencies 5. Business license data collection / application 6. Business management data analysis, statistics, application

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——MAH Counseling

MAH policy has effectively resolved the practical challenges faced by tech startups and research institutions in bringing their product to the market. It has addressed issues such as idle resources, manufacture facilities and equipment as well as insufficient work volume for skilled manufacturing personnel before their products’ marketization. Additionally, it prevents wastage of resources resulting from discrepancies between pre-market samples and post-market manufacturing, which includes the excessive utilization of funds before marketing and the extended recruitment of specialized personnel at various stages of manufacture. We provide the following related services: 1. Prompt dissemination of related regulations from various regions to ensure keeping up with the latest policy information 2. MAH mode planning, binding the 2 sets of supporting systems for R&D and manufacturing trustee 3. Trustee’s system evaluation to help license holder find suitable manufacturers 4. Establish quality systems and risk systems to provide the most reliable support for product marketing application 5. Simulation inspections of medical device GMP (Good Manufacturing Practice) to ensure a smooth inspection process for license holder 6. Supplier recommendation, covering from trustee manufacturers to product testing and raw material recommendation 7. System personnel training and assessment

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——GMP System Counseling

According to the requirements of the "Good Manufacturing Practice for Medical Devices", enterprises shall establish a quality management system suitable for the manufacturing and running of the medical devices and ensure their effective operation. Regarding the risk of medical devices, in order to manufacture safe, effective and quality standard compliant products, it is necessary to establish a set of quality systems based on hardware, supported by file system, and guaranteed by personnel, ensuring a systematic, coordinated and effective operation. We provide the following services: 1. Assessment of the existing systems and compliance gap analysis 2. Clean plant establishment and validation guidance 3. Common facilities verification counseling 4. Special process confirmation counseling 5. Design and development process support 6. Counseling / preparation / revision and improvement of quality system documents 7. Training and assessment of quality system personnel 8. Quality system manufacture workshop, manufacture equipment and other hardware compliance review 9. Quality system related regulations and knowledge training 10. Guide / accompany internal inspection / management review; 11. Medical device GMP system simulation assessment 12. Preparation, submission, tracking of quality system assessment materials until the inspection report is obtained 13. Writing / counseling of annual self-inspection report of medical device quality management system 14. Medical device product risk management periodic report writing / counseling 15. Quality management system improvement / rectification consultation

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——Testing Services

Our two medical device testing laboratories are located in Hangzhou and Suzhou, with 2000+ testing service item capabilities. We provide the following third-party tests: Medical device biocompatibility testing services (based on GB / T 16886, ISO10993 series standards) 1. Cytotoxicity test 2. Irritation test & skin sensitization test 3. Hemolysis test 4. Pyrogen test 5. Acute systemic toxicity test 6. Subacute / subchronic / chronic systemic toxicity test 7. Subcutaneous / muscle implantation test 8. In vivo degradation test 9. Genotoxicity test Animal testing studies 1. Animal efficacy studies 2. Animal pathology, toxicology research Physical and chemical characterization of medical devices 1. Material characterization 2. Chemical routine testing 3. Extractable and leachable studies 4. Chemical equivalence studies 5. Product function performance studies 6. Medical device and packaging stability studies 7. Degradability performance studies 8. Medical device and drug compatibility studies 9. Magnetic Resonance Imaging Compatibility Study (MRI) Microbiological testing and environmental testing of medical devices 1. Microbiological limit and sterility test 2. Bacterial endotoxin test 3. Medical device GMP production environment test 4. Purified water test 5. Biological safety cabinet, clean worktop test 6. Bacterial revert mutation test 7. Microbial barrier and antibacterial test Disinfection control and validation of medical devices 1. Cleaning, disinfection and sterilization verification 2. Sanitize and discard date verification Medical device aging verification 1. Shelf life verification of medical device products 2. Medical device transportation stability study 3. Packaging material expiration date study Active medical device electrical safety testing and EMC testing 1. Safety testing of medical electrical equipment (GB9706.1 series standard) 2. Safety testing of measurement control and laboratory equipment and in vitro diagnostic equipment (GB4793 series standard) 3. Electromagnetic compatibility testing (YY 9706.102, GB / T 18268.1, GB / T 18268.26) 4. Simulation of climatic environment and mechanical environment test 5. Product pre-test and rectification verification testing 6. Usability studies 7. Risk analysis studies 8. Performance and safety evaluation of post-marketing device use Medical software product consultation and testing 1. Testing of Software as a medical device (SaMD) and Software in a medical device (SiMD) 2. Medical device cybersecurity test 3. Quality assessment of health software 4. Individual performance tests for the quality of software products 5. Medical software usability test 6. Risk management, software development, software testing outsourcing and consulting services in the design and development stage 7. Programmable Medical Electrical Systems (PEMS) risk-related consulting services 8. Science and technology project acceptance test 9. Software product registry test In Vitro Diagnostic Products (IVD) 1. IVD product development and design services 2. IVD product performance testing services

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——Registration Testing Agent

We provide testing agency services for manufacturers with stereotyped products, assist companies to select appropriate national testing labs, write product technical requirements, submit testing materials, and provide advice on many aspects such as testing protocols, timeline planning, sample delivery requirements, rectification suggestions, etc., so as to track and ensure the testing progress.

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——Consulting Services

Depending on our clients' needs, we offer a wide range of customized consulting services, including but not limited to the following: 1) Regulatory Consultation 1. Medical device industry polices, updates and interpretation. 2. Global market access policies, updates and interpretation 2) Professional Training 1. Regulatory training 2. Quality management system training 3. Clinical trial management training 4. Other company-specific training 3) Medical Device Translation Services Our medical device translation team focuses on professional translation in the medical device industry, covering pre-market regulatory process, product testing, expert panel meeting, post-market surveillance, adverse events and other professional technical dossier translation, as well as simultaneous translation and conference interpretation services for various international medical device conferences. Our translation languages include English, Chinese, Japanese, German, French and other languages.

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——Product Strategy Planning

We assist our client in planning product registration strategy by distinguishing potential regulatory challenges and difficulties, and finding suitable paths to fast-track product commercialization, along with identifying estimated costs and timelines for all pivotal activities. We offer the following services: 1. Registration strategy analysis / Estimation of pre-registration costs and time 2. Registration execution strategy / Registration path risk assessment

泰格捷通（北京）医药科技有限公司

Beijing Tigermed-Jyton Co., LTD. ——Product Market Research

We can provide customers with market research services for designated products and provide product research reports, including product market size, competitive brands and competitive product analysis, target customer analysis, products’ medical insurance status, clinical use feedback, etc. The content of the report can be customized according to customer needs.

泰格捷通（北京）医药科技有限公司

Entity Management Services (Canada)

We provide corporate and entity management services to domestic and international clients. Collaborating closely with other law firms, tax advisors, and global service providers, we often act as our clients' single point of contact in Canada to deliver seamless corporate solutions. See: https://www.skylaw.ca/corporate-services

SkyLaw Professional Corporation

Securities Law Advice (Canada)

We offer strategic and proactive advice on securities law compliance involving both public and private issuers, including advice on prospectus exemptions, capital raising, control distributions and dissent rights. We can help prepare and file early warning reports, alternative monthly reports, reports of exempt distribution, press releases, SEDI (insider) filings and other materials.

SkyLaw Professional Corporation

Cross-border M&A (Canada)

We draw on deep experience to help buyers and sellers of both public and private businesses navigate complex M&A transactions and plans of arrangement, and to negotiate and close their deals. Leveraging our international experience and global network, we can coordinate or provide the right legal advice - wherever in the world it is needed.

SkyLaw Professional Corporation

外籍员工工作 / 居留许可支持 – 南非

Equinox（EQN）是一家泛非洲商业服务平台，通过设于北非、东非、西非及南部非洲的区域中心，以单一责任主体模式提供整合的企业、合规、税务、薪酬及业务支持服务，业务覆盖 30 多个非洲司法辖区。 按业务量计费；不含政府 / 领事馆规费。

Equinox Group

非周期薪酬处理 – 南非

Equinox（EQN）是一家泛非洲商业服务平台，通过设于北非、东非、西非及南部非洲的区域中心，以单一责任主体模式提供整合的企业、合规、税务、薪酬及业务支持服务，业务覆盖 30 多个非洲司法辖区。 奖金或重新计算；按员工或月度基数的 25% 计费，取较高者。

Equinox Group

UIF / SDL 失业保险与技能发展税登记 – 南非（每位新员工）

Equinox（EQN）是一家泛非洲商业服务平台，通过设于北非、东非、西非及南部非洲的区域中心，以单一责任主体模式提供整合的企业、合规、税务、薪酬及业务支持服务，业务覆盖 30 多个非洲司法辖区。 每位新员工的一次性 UIF / SDL 登记。

Equinox Group

月度薪酬处理 – 南非（每位员工）

Equinox（EQN）是一家泛非洲商业服务平台，通过设于北非、东非、西非及南部非洲的区域中心，以单一责任主体模式提供整合的企业、合规、税务、薪酬及业务支持服务，业务覆盖 30 多个非洲司法辖区。 按员工每月处理；按员工人数分级。

Equinox Group

薪酬系统建置 – 南非

Equinox（EQN）是一家泛非洲商业服务平台，通过设于北非、东非、西非及南部非洲的区域中心，以单一责任主体模式提供整合的企业、合规、税务、薪酬及业务支持服务，业务覆盖 30 多个非洲司法辖区。 一次性薪酬系统建置；按员工人数分级（1–500）。

Equinox Group

A Director's Perspective: Exposure, Risks and Personal Liability

In this article, Mark Lee Chambers Law Corporation explores the fundamental paradox facing corporate leaders: while the company itself operates under the shield of limited liability, directors remain exposed to direct personal liability when breaching their duties.

Mark Lee Chambers Law Corporation

Shareholders' Agreement

This Article by Mark Lee Chambers Law Corporation explains the importance behind a well drafted and comprehensive agreement between shareholders and examines both the legal underpinnings of these contracts and explores practical options for allocating rights and liabilities across different business scenarios.

Mark Lee Chambers Law Corporation

Shareholder Disputes: Oppression, Buyout Orders, Share Valuation

This Article by Mark Lee Chambers Law Corporation explores both the legal and technical aspects of shareholder oppression claims and business / share valuations.

Mark Lee Chambers Law Corporation

Shareholder Decisions - The Power of the Vote

When corporate management is vested solely in the Board, can shareholders ever make business decisions for the company? This Article by Mark Lee Chambers Law Corporation examines the rare exceptions to this rule and outlines the factors courts consider when allowing shareholders to intervene in corporate management.

Mark Lee Chambers Law Corporation

Shareholder - The Concept of Rights & Liabilities

This Article by Mark Lee Chambers Law Corporation examines the legal relationship between a company and its shareholders post-incorporation, focusing on the specific rights shareholders retain when day-to-day management is vested entirely in the Board.

Mark Lee Chambers Law Corporation

Share Buyout - Applicability of Discounts

When courts find shareholder oppression, a share buyout is a common enough remedy to the aggrieved shareholder. This Article by Mark Lee Chambers Law Corporation discusses the circumstances under which valuation discounts may be applied when the court orders a buyout to remedy the oppression.

Mark Lee Chambers Law Corporation

Power to Grant Relief - A Director's Liability under Section 391 of the Companies Act 1967

This Article by Mark Lee Chambers Law Corporation explores the reliefs a director might seek under section 391 of the Companies Act 1967 when facing legal action for a breach of director's duties.

Mark Lee Chambers Law Corporation

Testifying from Outside Singapore - the Video Link Exception in Multi-Jurisdictional Disputes

With multi-jurisdictional disputes on the rise and the unavoidable need for witness testimony, this Article by Mark Lee Chambers Law Corporation explores the general principles and considerations factored by the Singapore Courts in deciding whether to exercise its discretion to receive oral evidence by video link in civil proceedings.

Mark Lee Chambers Law Corporation

Lifting the Veil of of Incorporation

This Article by Mark Lee Chambers Law Corporation discusses the concept of the separate legal personality following the incorporation of a company in Singapore.

Mark Lee Chambers Law Corporation

Investing in Singapore: A Foreign Investor's Guide

This Joint Article between Marigold Consultancy and Mark Lee Chambers Law Corporation presents a bite-sized roadmap for readers looking to expand or anchor their businesses in Singapore.

Mark Lee Chambers Law Corporation

Directors - The Concept of Duties & Liabilities

This Article by Mark Lee Chambers Law Corporation discusses the concept of directorships in Singapore and explains that while the law recognises only one form of directorship, in practice, there are several kinds of directors including executive and non-executive directors. All owe fiduciary duties to the company.

Mark Lee Chambers Law Corporation

Derivative Action by Shareholders

This Article by Mark Lee Chambers Law Corporation discusses the very common scenario of a deadlock between a company and its shareholders. We discuss specific circumstances where a shareholder's request for enforcement and accountability are rebuffed by the Board.

Mark Lee Chambers Law Corporation

Companies - Corporate Personality

This Article by Mark Lee Chambers Law Corporation provides an overview on how companies are incorporated in the Republic of Singapore and explains the effects of incorporation and the relationships between the company and its shareholders after incorporation.

Mark Lee Chambers Law Corporation

Case Update: Sakae Holdings Ltd [2018] SGCA 33

This Case Update by Mark Lee Chambers Law Corporation discusses the decision made by the highest court in the Republic of Singapore relating to minority oppression claims brought under Section 216 of the Companies Act 1967. The important distinction is drawn between personal wrongs suffered by a shareholder and corporate wrongs committed against the company, and in what situations may a finding of commercial unfairness be found to support a claim for oppression.

Mark Lee Chambers Law Corporation

Case Highlight: Reverse Oppression

This Case Highlight by Mark Lee Chambers Law Corporation discusses the topic of whether a majority shareholder may ever be "oppressed" by the minority.

Mark Lee Chambers Law Corporation

Case Highlight: Shareholder Oppression and the Relevance of a Buyout Remedy

This Case Highlight by Mark Lee Chambers Law Corporation discusses a decision made by the High Court of the Republic of Singapore to dismiss an application made by the majority shareholders to strike out a minority shareholder's claim for oppression, on grounds that a buyout offer had already been made. The majority shareholders' application was successfully resisted.

Mark Lee Chambers Law Corporation

Access to a Company's Documents & Records

This Article by Mark Lee Chambers Law Corporation explores a director's rights of inspection vis-a-vis company documents and the avenue one has when his/her entitlement is restricted.

Mark Lee Chambers Law Corporation

法律动态更新——2026年2月——《2025年投资法》将于2026年3月1日起正式生效，为投资者和企业引入了关键性变革

2020年至2025年期间，地缘政治局势剧烈动荡。投资活动与全球供应链均经历了重大重组。人们普遍观察到，总体投资流向，尤其是新一代外商直接投资（FDI），已不再主要受低成本优势或短期激励措施的驱动。相反，其投资方向日益倾向于那些能够提供稳定投资环境、具备政治、社会、环境和技术基础设施高度融合优势，以及对可持续发展标准作出坚定承诺的地区。

Bizconsult Law Firm

Special Report on Nutrition and Health Foods for China’s Middle-Aged and Elderly Population

As China’s population aging continues to deepen, nutritional and health issues among the middle-aged and elderly have become increasingly prominent, making this an important component of advancing the Healthy China strategy. Demand from middle-aged and elderly consumers in the nutrition products sector continues to grow, driving steady expansion of the nutrition and health food market, while consumer needs are becoming increasingly diversified and precise. Against this backdrop, based on in-depth research into the field of nutrition and health for China’s middle-aged and elderly population, CIC and QuantumPharm/Quantum Song? Wait—need accurate translation. Better neutralize: CIC Insight Consulting and Quantum Song (NASDAQ: QSG) jointly released the 2024 China Middle-Aged and Elderly Nutrition and Health Food Report: Nourishing the Silver Years, Insights into the Consumption Landscape of Nutrition and Health Among Middle-Aged and Elderly Consumers. The report provides a comprehensive analysis of the current state of nutrition and health consumption among China’s middle-aged and elderly population, key trends and characteristics, consumer pain points, and future industry development trends.

灼识咨询

White Paper on the New-Style Tea Beverage Industry

Recently, the 2nd China New-Style Tea Beverage Industry Conference, hosted by the China New-Style Tea Beverage Industry Alliance, was successfully held at the National Exhibition and Convention Center in Shanghai. During the conference, CIC, together with the China New-Style Tea Beverage Industry Alliance, jointly released the White Paper on the New-Style Tea Beverage Industry. Zhu Yue, Partner at CIC, attended as a representative of the invited consulting institution and joined more than 100 tea beverage brands from across the country to explore breakthrough paths under the theme of “Differentiation • A New Journey.” Zhu Yue stated that the new-style tea beverage industry is undergoing continuous innovation and transformation, and that the White Paper on the New-Style Tea Beverage Industry addresses issues of market concern from multiple perspectives, including recent investment hotspots, interpretation of the industry chain, and industry development trends, giving it important practical and strategic significance in the current environment. The white paper received strong attention and praise from conference guests and continued to generate significant interest after the event.

灼识咨询